Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash $ 6,389,839 $ 1,479,166
Prepaid expenses & other current assets 76,440 7,995
Inventory 233,742 121,994
Total Current Assets 6,700,021 1,609,155
Fixed Assets, net of accumulated depreciation 6,644,490 3,763,332
Other Assets 188,701 529,863
TOTAL ASSETS 13,533,212 5,902,350
Current Liabilities    
Accounts payable and accrued liabilities 712,260 804,138
Notes payable, net of discount 700,015
Contingent stock liability 677,000
Contingent warrant liability 585,000
Warrant liability 3,101,102
Total Current Liabilities 3,813,362 2,766,153
Commitments and Contingencies (Note 15)  
Subsequent Event (Note 16)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 1 share issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 9,207,415 shares issued and outstanding at September 30, 2022 (5,187,062 shares issued and outstanding December 31, 2021) 922 519
Common stock subscription receivable (32,500)
Additional paid-in capital 24,367,585 13,835,882
Accumulated other comprehensive loss (190,863)
Accumulated deficit (14,457,794) (10,667,704)
Total Stockholders’ Equity 9,719,850 3,136,197
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 13,533,212 $ 5,902,350